Articles Vol. 67 No. 9 24/09/2026

SWOMEN’S ACCEPTABILITY OF COMMUNITY-BASED CERVICAL CANCER SCREENING USING HPV DNA TESTING IN HAI PHONG, VIETNAM

Ong The Due, Nguyen Thi Van Anh, Pham Tuan Viet, Dao Anh Son
DOI: 10.52163/yhc.v67i9.6718
0 Views
0 Downloads
Abstract

Objective: To describe women’s acceptability of HPV DNA testing for community-based cervical cancer screening in Hai Phong, Vietnam.

Methods: A cross-sectional descriptive study was conducted in Thuy Nguyen and Vinh Bao districts, Hai Phong City. A total of 722 women who underwent HPV DNA testing and completed the survey questionnaire were included in the analysis. Data were presented using frequencies, percentages, means, and standard deviations.

Results: Overall acceptability of HPV DNA testing was very high: 98.7% of participants reported feeling comfortable with the testing process, and 98.6% accepted this method. Among participants, 47.9% performed self-sampling, while 52.1% had samples collected by health care workers. In the self-sampling group, 97.7% considered the method convenient, 97.4% did not feel embarrassed, and 92.5% were confident that the sample was collected correctly. In the health care worker sampling group, 99.2% considered the method convenient and 99.4% trusted that the sample was collected correctly. Willingness to use the method regularly reached 95.1% in the self-sampling group and 98.4% in the health care worker sampling group.

Conclusion: HPV DNA testing showed high acceptability when implemented in community settings. Providing flexible options for both sampling approaches, combined with adequate counseling and strengthening the role of primary health care, may contribute to expanding cervical cancer screening coverage in Vietnam.

References
[1]
1. Tổ chức Y tế thế giới. Cervical cancer. 2025. Truy cập tại: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer Google Scholar
[2]
2. Ji X, Hao M, Wang Y, Kong W, Pan Z, Sun Q, et al. Human papillomavirus self-sampling in Asia: a systematic review. Front Microbiol. 2025 Mar 14;16. doi:10.3389/fmicb.2025.1540609 Google Scholar
[3]
3. International Agency for Research on Cancer. Viet Nam - Global Cancer Observatory (GLOBOCAN 2022). 2024. Google Scholar
[4]
4. UNFPA Vietnam. An Investment Case Study on HPV vaccination in Viet Nam. Truy cập tại: https://vietnam.unfpa.org/en/publications/investment-case-study-hpv-vaccination-viet-nam Google Scholar
[5]
5. Abila DB, Wasukira SB, Ainembabazi P, Kiyingi EN, Chemutai B, Kyagulanyi E, et al. Coverage and Socioeconomic Inequalities in Cervical Cancer Screening in Low- and Middle-Income Countries Between 2010 and 2019. JCO Glob Oncol. 2024 Jun;(10):e2300385. doi:10.1200/GO.23.00385 Google Scholar
[6]
6. Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022 Dec 2;22(1):486. doi:10.1186/s12905-022-02043-y Google Scholar
[7]
7. Nishimura H, Yeh PT, Oguntade H, Kennedy CE, Narasimhan M. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Glob Health. 2021 May;6(5). doi:10.1136/bmjgh-2020-003743 PubMed PMID: 34011537; PubMed Central PMCID: PMC8137189. Google Scholar
[8]
8. Paula-Pinto M, Amaral M, Norton L, Vilas-Boas F, Ferreira V, Santos-Silva I. Vaginal self-versus clinician sampling on cervical cancer screening: an accuracy and acceptability systematic review and meta-analysis. Rev Port Med Geral E Fam. 2025 Mar 5;41(1):52–64. doi:10.32385/rpmgf.v41i1.13988 Google Scholar
[9]
9. Morgan K, Azzani M, Khaing SL, Wong YL, Su TT. Acceptability of Women Self-Sampling versus Clinician-Collected Samples for HPV DNA Testing: A Systematic Review. J Low Genit Tract Dis. 2019 Jul;23(3):193. doi:10.1097/LGT.0000000000000476 Google Scholar
[10]
10. Madzima TR, Vahabi M, Lofters A. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review. Can Fam Physician. 2017 Aug 1;63(8):597–601. PubMed PMID: 28807952. Google Scholar